+ All Categories
Home > Documents > CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW...

CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW...

Date post: 03-Aug-2020
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
35
www.mghcme.org CBT to Augment Psychopharmacology Michael W. Otto, PhD Department of Psychological and Brain Sciences Boston University
Transcript
Page 1: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

CBT to Augment Psychopharmacology

Michael W. Otto, PhD Department of Psychological and Brain Sciences

Boston University

Page 2: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Disclosures

I have the following relevant financial relationship with a commercial interest to disclose: NIMH, NIDA Grant Support Book Royalties - Oxford University Press, Routledge

Page 3: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

The Approach Today Adding a Few New Strategies to Your Practice

• An obsession with efficiency • Repeated attention to emotional

regulation/emotional intolerance • Focus on additions to Current Practice

– A few core principles for change – A few core strategies, complete with metaphors

Page 4: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

What I am not talking about

Moderate Exercise is a terrific augmentation strategy. Exercise:

• Improves mood • Treats depression • Treats anxiety and anxiety disorders • Improves cognition • Enhances sleep

• In short, prescribing exercise is a wonderful way to

achieve a range of beneficial outcomes...with the side effect of living longer

Page 5: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

The good news... combination treatment works!

Enhances outcome for anxiety disorders (panic, GAD) Enhances outcome for chronically, more-severely depressed patients Enhances maintenance of treatment gains (with medication discontinuation if desired) Enhances outcome for bipolar disorder Enhances medication adherence A great strategy for medication non-responders (failing medication does not predict failure in CBT, depending on the disorder)

Page 6: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

The bad news...combination treatment is less than we desire Modest gains for combination for many disorders

Anxiety and mood disorders in particular

There are potential interference effects of medications on CBT:

Context effects, maintenance of treatment gains Cortisol or other central learning effects

NONETHELESS: Except CBT almost always appears to have strengths in maintenance of treatment gains Strengths in non-responders .......so......

Page 7: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Page 8: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Treatment Session

• A weekly, 50-minute session accounts for less than 1% of a patient’s waking lives

• How do we get the 1% to have an influence over the 99%

Page 9: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

A Few Standard Strategies to Jump the Gap

• Co-therapist on the case • Patient workbook (hear it, see it, read it) • Programmed home practice (homework) • Practice in relevant contexts in session

– Role playing – High emotion

• Practice across contexts – Relapse Prevention - Over-rehearsal

• Vivid and/or emotional examples

Otto (2000). Cognitive and Behavioral Practice, 7, 166-172.

CORE SLIDE 1

Page 10: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Addressing Medication Context Effects

CBT can works well within contexts, and across programmed changes in context: • Need to attend to attribution of treatment

effects (add CBT during stable doses) • If medication use changes, CBT may need to

be reapplied • Use a renewal course of CBT across

medication discontinuation

Page 11: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Safety Behaviors

• What are safety behaviors? – Actions taken to avoid, prevent, or manage a potential

threat • Examples

– Avoidance – Checking (pulse, exits, hospitals) – Carrying aids (rescue medications, cellular phones)

• Effective in short-term • Maladaptive in long-term because people may fail to learn

that they are safe

Page 12: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Cotherapist on the Case

Page 13: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Session 1 - Establishing a Cotherapist on the Case

To help the patient be an active cotherapist in treatment, provide a: •Model of the disorder (break the cascade of thoughts and emotions into elements) •Model of the change process •Information on the role of the patient

Page 14: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

End of Treatment

• Patient has skills to act as his or her own therapist

• Patient focuses on well-being • Therapist contact fades

Page 15: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

10 Minute CBT: Cognitive Interventions

• Goal: Help patients take a step back from treating thoughts as truth. Learn to treat thoughts as guesses about the world.

• Classic Tools: Information, Socratic questioning, self-monitoring, behavioral experiments

• Styles of the Masters: Beck, Ellis, Meichenbaum • 10 Minute CBT: CEO Thinking (mindfulness) Marveling Echoing Metaphors

CORE SLIDE 2

Page 16: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

What is the evidence that the automatic thought is true? Not true? Is there an alternative explanation? What is the worst that could happen? Would I

live through it? What’s the best that could happen? What’s the most realistic outcome?

Page 17: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

What is the effect of my believing the automatic thought? What is the cognitive error? If a friend was in this situation and had this

thought, what would I tell him/her?

Page 18: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

10 Minute CBT: Cognitive Interventions

• Anxiety (what if...) – Over-estimating the probability of negative outcomes – Assuming the consequence will be unmanageable

• Depression (look at me...)

– The comparator (depression about depression) – Negative view of self, world, future

• Sleep

– Cost of low sleep

Page 19: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

10 Minute CBT: Exposure Interventions

• Goal: Step by step relearning of safety and comfort around feared situations (or feelings)

• Classic Tools: In vivo, imaginal, interoceptive • Cognitive vs. Non-cognitive perspectives • 10 Minute CBT:

Information Emotional Acceptance (what are you doing in response to your

anxiety) Exposure Self-Care (what will I feel, how will I coach myself) Goal for the situation Safety behaviors

CORE SLIDE 3

Page 20: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

10 Minute CBT: Activity Interventions

• Goal: Return patients to rewarding and enjoyable activity

• Classic Tools: Monitor and Assign (values work) • 10 Minute CBT: Troubleshooting The “feel” of getting better Exercise

CORE SLIDE 4

Page 21: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

• A nice reminder that “doing” in therapy is important

• Primary treatment strategies – Self-monitoring of daily activities and mood – Week-by-week scheduling of activities that bring

patients a sense of pleasure or mastery – Identifying and reducing avoidance behaviors that

increase depressive symptoms.

Behavioral Activation (BA) Treatment

Page 22: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Emotional Intolerance • Predicts all sorts of maladaptive behavior

– Exercise avoidance – Emotional eating – Smoking for coping motives, early lapse – Drinking for coping motives – Dropout of drug treatment – Lack of persistence toward goals (when negative affect is present) – Disability from dyspnea

• Elevated in most disorders • Anxiety Sensitivity Index is a great measure • A range of ways to treat:

– Exposure – Mindfulness

CORE SLIDE 5

Page 23: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Uh oh! What if:

•This gets worse? •I lose control?

•This is a stroke?

I have to control this!

Panic Cycle Relative Comfort

•Notice the sensation

•Do nothing to control it.

•Relax WITH the sensation

Page 24: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Common Interoceptive Exposure Procedures

• Headrolling – 30 seconds - dizziness, disorientation • Hyperventilation – 1 minute - produces dizziness

lightheadedness, numbness, tingling, hot flushes, visual distortion • Stair running – a few flights – produces breathlessness, a pounding

heart, heavy legs, trembling • Full body tension – 1 minute – produces trembling, heavy muscles,

numbness • Chair spinning – several times around – produces strong dizziness,

disorientation • Mirror (or hand) staring – 1 minute – produces derealization

Page 25: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Page 26: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Exposure Interventions

• Provide rationale for confronting feared situations

• Establish a hierarchy of feared situations • Provide accurate expectations • Repeat exposure until fear diminishes • Attend to the disconfirmation of fears (“What

was learned from the exposure?”)

Page 27: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Situational Exposure Guidelines

• Prior to completing in-vivo exposures, create a fear hierarchy identifying feared and avoided situations

• Identify safety behaviors- actions taken to avoid, prevent, or manage a potential threat – Avoidance – Checking (pulse, exits, hospitals) – Carrying aids (rescue medications, cellular phones)

Page 28: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Learning Safety in Panic

Interoceptive exposure • Feared sensations become safe sensations

– in the office with the therapist – at home – independent of the treatment context

Page 29: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Situational Exposures

• Rationale: – Providing a new learning opportunity to examine

negative predictions about feared outcomes – Increasing tolerance to internal sensations in

feared situations

Page 30: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Problem Solving Interventions

• Strong effect sizes for problem solving therapy for depression (Bell & E’Zurilla, 2009, Clin Psychol Rev)

• Elements: – Training in a positive problem orientation – Training in problem-solving skills:

• problem definition and formulation • generation of alternatives • decision making • solution implementation and verification

Page 31: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Medication Adherence

• Establishing a cotherapist on the case • Motivation: link pill taking to desired outcomes

– Meaning of the pill – Meaning of treatment

• Strategies: link pill taking to lifestyle – Cues for use

• Rehearsals: do it and monitor • Repeat the intervention (memory effects)

Otto et al. J Affective Dis. 2003;13:171-181.

Page 32: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Motivational Interviewing?

Page 33: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Motivational Interviewing!

• Philosophy – Motivation to change is elicited from the client – It is the patient’s task to articulate and resolve

ambivalence – Direct persuasion is not an effective method for

resolving ambivalence

• Strategies – Provision of assessment feedback – Discussion of values and pros and cons of change

Rollnick and Miller. Behav Cogn Psychotherapy. 1995;23:325-334. www.motivationalinterview.org.

Page 34: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

Relapse Prevention

• Patient as therapist • Treatment contract • Training in early detection • Use of treatment team

Otto et al. J Affective Dis. 2003;73:171-181.

Page 35: CBT to Augment Psychopharmacologymedia-ns.mghcpd.org.s3.amazonaws.com/psychopharm2015/...• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders:

www.mghcme.org

A few core citations • Hofmann SG et al. . Is it Beneficial to AddPharmacotherapy to Cognitive-Behavioral Therapy when Treating Anxiety

Disorders? A Meta-Analytic Review. Int J Cogn Ther. 2009 Jan 1;2(2):160-175. • Furukawa TA et al.. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004364. • Guidi J et al. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive

disorder: a preliminary meta-analysis. Psychol Med. 2011 Feb;41(2):321-31. • Lynch FL et al.. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective

serotonin reuptake inhibitor-resistant depression:treatment of SSRI-resistant depression in adolescents trial findings. Arch GenPsychiatry. 2011 Mar;68(3):253-62.

• Otto, MW et al.. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice, 2005, 12, 72-86.

• Otto MW et al. (2009). The efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biological Psychiatry,2009, 67, 365-370.

• Otto MW et al. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: Medication effects, glucocorticoids, and attenuated outcomes. Clinical Psychology: Science and Practice, 2010, 17, 91-103.

• Otto, MW et al. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behaviour Research and Therapy, 2010, 48, 720-727.

• Watanabe N, Churchill R, Furukawa TA. Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review. BMC Psychiatry. 2007 May 14;7:18.


Recommended